A B S T R A C T Conversion of thyroxine (T4) to 3,5,3'-triiodothyronine (T3) in rat brain has recently been shown in in vivo studies. This process contributes a substantial fraction of endogenous nuclear T3 in the rat cerebral cortex and cerebellum. Production of T4 metabolites besides T3 in the brain has also been suggested. To determine the nature of these reactions, we studied metabolism of 0.2-1.0 nM [125I]T4 and 0.1-0.3 nM [1311]T3 in whole homogenates and subcellular fractions of rat cerebral cortex and cerebellum. Dithiothreitol (DTT) was required for detectable metabolic reactions: 100 mM DTT was routinely used. Ethanol extracts of incubation mixtures were analyzed by paper chromatography in t-amyl alcohol:hexane: ammonia and in 1-butanol:acetic acid. Rates of production of iodothyronines from T4 and T3 were greater at pH 7.5 than at 6.4 or 8.6 and greater at 37°C than at 220 or 4°C. Lowering the pH, reducing the protein or DTT concentrations, and preheating homogenates to 100°C all increased excess 1-production but reduced iodothyronine production.
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In cerebral cortical homogenates from normal rats, products of T4 degradation were as follows (percent added T4+SEM in nine experiments): T3, 1.9±0.5%; 3,3',5'-triiodothyronine (rT3), 34.0+2.4%; 3,3'-diiodothyronine (3,3'-T2), 5 .8+1.6%; 3'-iodothyronine (3'-T,), c2.5%; and excess I-, 4.7±1.2%. In the same experiments, products of T3 degradation were 3,3'-T2, 63.3 +5.5%, and 3'-T,, 12 .6±1.4%. Cerebral cortical homogenates from hyperthyroid rats and normals were similar in regard to T4 to T3 deiodination. In contrast, in cerebral cortical homogenates from hypothyroid rats, phenolic ring deiodination rates were increased and tyrosyl ring A portion of this work was presented at the Annual Meeting of the American Federation for Clinical Research, May 1980, Washington, D. C., and appeared in abstract form in Clin. Res. 28: 262A.
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T4 to T3 conversion rates in cerebellar homogenates were greater than rates in cerebral cortical homogenates from the same normal rats and less than rates in cerebellar homogenates from hypothyroid rats. T4 and T3 tyrosyl ring deiodination rates were greatly diminished in cerebellar homogenates compared with cerebral cortical homogenates in normal and hypothyroid rats. High-speed (1,000-160,000 g) pellets from cerebral cortical homogenates were enriched in phenolic and tyrosyl ring deiodinating activities relative to cytosol. Fractional conversion of T4 to T3 was inhibited by T4, iopanoic acid, and rT3, but not by T3. Tyrosyl ring deiodination reactions were inhibited by T3, T4, and iopanoic acid, but not by rT3.
These studies demonstrate separate phenolic and tyrosyl ring iodothyronine deiodinase enzymes in rat brain. The brain phenolic ring deiodinase serves in vivo as a T4 5'-deiodinase and closely resembles anterior pituitary T4 5'-deiodinase in physiological and biochemical characteristics. The physiological significance of the tyrosyl ring iodothyronine deiodinase enzyme is unclear; it shares several properties with rat hepatic T4 5-deiodinase.
INTRODUCTION
In clinical medicine, the brain is clearly responsive to excessive and deficient supplies of thyroid hormones. Congenital hypothyroidism is accompanied by morphological abnormalities of the cerebral cortex and cerebellum and by corresponding derangements of central nervous system function in man and other species (1-5) (see [1] [2] [3] [4] forrecentreviews). Both hyperthyroidism and hypothyroidism cause abnormalities of cognitive function in adult patients (6, 7) . The molecular events necessary for the expression of thyroid hormone effects on the brain remain-poorly understood.
3,5,3'-triiodothyronine (T3)l binding sites in rat brain cells with physical properties similar to those of nuclear T3 receptors in other rat tissues. They found differences in the maximal nuclear T3 binding capacity in different areas of the brain (9), and they and others have described changes in cortical and cerebellar nuclear T3 binding with age in newborn rats (10, 11 and isolated cell nuclei from the cerebral cortex and cerebellum. They found that a substantial fraction of nuclear T3 in these regions was produced locally and that in vivo iopanoic acid treatment abolished the appearance oflocally produced nuclear T3.
In vitro studies of metabolism of thyroid hormones in brain tissue have also been reported. Tata et al. (18) found degradation of [131I]T4 and ['311]T3 in brain homogenates of chickens and dogs. They tentatively identified tetraiodothyroacetic acid and triiodothyroacetic acid, or the analogous propionic acid derivatives, as minor products. They also found that small amounts of degraded T4 sometimes appeared as T3, but iodide constituted the great bulk of the identifiable T4 degradation products in their stuidies. We (19, 20) and Chopra (21) (upper phase); T4, thyroxine; T,  3,5,3'-triiodothyronine; rT3, 3,3',5'-triiodothyronine; 3,3'-T2,  3,3'-diiodothyronine; 3',5'-T2, 3',5'-dijodothyronine; 3'-TI,   3'-iodothyronine. enates of other tisstues (19) (20) (21) , but was diffictult to detect against the background of T3 contaminating the large quantities of T4 used.
To establish the biochemical characteristics of T4 5'-deiodination in brain, we have reexamined T4 metabolism in vitro, using a sensitive radiometric technique for identification and quantitation of reaction products. We investigated the effects of hypothyroidism and hyperthyroidism, since both of these conditions stimulate T4 5'-deiodinase activity in some tissues (20, 22, 23 Analytical methods. 75-125 ,1. of the ethanolic extracts was mixed with carrier T4, T3, and Nal, and subjected to descending paper chromatography using the t-amyl alcohol:hexane:2 N ammonia::5:1:6 (TAA) system of Bellarbarba et al. (26) . Carriers were identified by spraying with color reagents.2 In some experiments, various peaks of radioactivity were eluted from unsprayed chromatograms with methanol:ammonia (99:1). These were concentrated under a stream of nitrogen, mixed with carrier compounds, and chromatographed again either in the TAA system or in a descending paper system of 1-butanol:acetic acid:water (78:5:17) (BAA) (27) .
In experiments designed to identify reaction products, chromatograms were cut into 1-cm segments. In subsequent experiments, TAA chromatograms were cut into 10 segments. The I-, T4, and T3 carrier spots were in segments 2, 5, and 9, respectively. Segments 1-9 were -2.5 cm in length, while segment 10 was between T3 and the front. Changes in '25I and 1311 in segments 6-8 were attributed to 3,3'-diiodothyronine (3,3'-T2), changes in '25I in segments 3 and 4 were attributed to rT3 and changes in '3'I in segments 4 and 5 were attributed to 3'-iodothyronine (3'-T,) ( Paper electrophoresis employed a Durrum-type cell (Beckman Instruments, Inc.) in 0.3 M glycine-0. 15 M acetate buffer, pH 8.6. Protein was measured in triplicate by the method of Lowry et al. (29) . Since DTT strongly interferes in the protein assay, homogenate aliquots and bovine serum albumin standards were precipitated with 5 ml 7% perchloric acid, pelleted, washed with the same amount of perchloric acid, pelleted again, and dissolved in 0.1 N NaOH.
Calculations. Each experiment included extracts of Trissucrose-100 mM DTT made immediately after addition of tracer (zero time) and incubations with Tris-sucrose-100 mM DTT for 2 h. The percent radioactivity in each segment of the chromatograms from the 2 h incubations with Tris-sucrose-100 mM DTT was subtracted from the percent radioactivity in the corresponding segments from incubations containing brain tissue. This figure for each chroinatogram segment was divided by the percent radioactivity in the zero-time [1251IT4 or [131I]T3 spots, as appropriate, to yield the fraction of added T4or T3 degraded or the fractions of added T4 to T3 converted by the tissue to the various reaction products. Measured quantities of 5'-deiodination products of T4 were doubled to correct for simultaneous 1251-production. Statistical comparisons were made using the t test for paired or unpaired values as appropriate, and by two-way analysis of variance, using the statistical package of Hewlett-Packard 9815A programmable calculator (Hewlett-Packard Co., Palo Alto, Calif.).
RESULTS
Characterization of reaction products. The distributions of radioactivity on chromatograms of zerotime extracts of cerebral cortical homogenates and of Tris-sucrose-100 mM DTT were indistinguishable from the distribution of radioactivity of chromatograms of original tracer solutions. In these chromatograms, peaks of 1251 radioactivity were found only in the I-and T4 carrier spots, and peaks of 131I radioactivity were found only in the I-and T3 carrier spots. There was no evidence of formation, during extraction or thereafter, of T4 or T3 esters or of complexes of T4 to T3 with ethanol-soluble lipids. After 2-h incubations with Trissucrose, with Tris-sucrose-100 mM DTT in the absence of tissue, or with whole cerebral cortical homogenates from normal or hypothyroid rats without DTT, the percent of total 1251 and 1311 radioactivity in the iodothyronine spots was 1-5% lower than that at zero time. Approximately half of this change was accounted for by an increase in radioactivity in the iodide spot, but the rest of the loss of starting material was not matched by the appearance of radioactivity in any other discrete area of the chromatograms. In particular, in these incubations, <1% of added [1251]T4 radioactivity appeared in the T3 spot after 2 h.
Incubation In both systems, all of the '25I and 131I radioactivity coincided with the 3,3'-T2 standard. In the BAA system, tetraiodothyroacetic acid, Hf = 0.92, was completely distinct from 3,3'-T2, B1 = 0.77, and there was no radioactivity in the tetraiodothyroacetic acid spot above background. In some experiments, the formation of 3',5'-T2 seemed possible. This compound is not separable from 1-in the TAA system (28) and not separable from T4 in the BAA system (27) ; however, apparent 1-production in individual samples could be compared in both systems. When this was carried out for incubation samples suspected ofcontaining 3',5'-T2, there was no significant difference by which the presence of3',5'-T2 could be inferred. There was never any radioactivity of TAA chromatograms compatable with the formation oftriiodothyroacetic acid from T4 or T3 (27) .
Effects of varying incubation pH, temperature, and time. When the pH of the incubations was adjusted to 6.4 or 8.6, the T4 to T3 and T3 to 3,3'-T2 conversion rates were <50% ofthe rates at pH 7.5. Likewise, there was a progressive decrease in the rates of these reactions when the temperature was lowered to 220 and 4°C. Heating the homogenates or high-speed pellets in a boiling water bath for 30 min abolished detectable production of any iodothyronines from T4 or T3. When whole cerebral cortical homogenates from normal and from hypothyroid rats were sampled every 30 min for 120 min, plots oflog (percent added T4 or T3 remaining) vs. time were linear. Thus, the fractional degradation rates of T4 and T3 were constant during this period. In Table I and Fig. 2) . The following alterations in incubation conditions all increased excess I-production up to 40% of the added T4 and 10% of the added T3: pH 6.5, decreased protein concentration (particularly in the high-speed pellet), decreased DTT concentration, and preheating to 100°C for 30 min. All of these conditions caused greatly decreased net formation of iodothyronines, and formation of I-from T3 was never rapid enough to explain more than a small part ofthe excess 1-from T4. When 1-production was analyzed by BAA mixtures from normal and hyperthyroid rats the estimated upper limit for production of both 3',5'-T2 and X-T, was 2.5% ofthe added T4 in 2 h. In the incubations of normal and hyperthyroid cerebral cortex, the only significant effect of increasing the T4 concentration from 0.2 to 100 nM was to decrease the total degradation of T4 in the normal group from 33.2+7.3 to 27.1 ±6.8% (P < 0.05 by paired t test).
In homogenates of cerebral cortex from hypothyroid rats (Fig. 2, left T3 production rates in cerebral cortical homogenates from hypothyroid rats could be approximated well as the sum of net T3 and net 3,3'-T2 production. In two experiments using 100 nM initial T4 concentration (one shown in Fig. 2 (Table I) . The mean T, to T3 conversion rate in cerebellar homogenates from hypothyroid rats was the same as that in cerebral cortical homogenates from the hypothyroid rats, and much greater than in the cerebellar homogenates from the normal rats. In dramatic contrast, there was little or no T4 to rT3 conversion in cerebellar homogenates from normal or hypothyroid rats. T3 to 3,3'-T2 conversion was present in cerebellar homogenates from normal rats but was much slower than in cerebral cortical homogenates. T3 to 3,3'-T2 conversion was not detectable in cerebellar homogenates from hypothyroid rats. Thiol dependence of deiodination reactions. Whole homogenates of cerebral cortex from normal and hypothyroid rats were incubated with tracer T4 and T3 in the presence of 0-100 mM DTT. There was no detectable degradation of T4 or T3 in the absence of DTT. In the hypothyroid preparations (Fig. 3) (Fig. 4) , the rate of T4 to rT3 conversion and the rate of T3 to 3,3'-T2 conversion increased progressively as the DTT 50 mM, with no significant differences between 50 and 100 mM DTT. The production of 3'-T1 from T3 had a similar relationship to the DTT concentration. In normal rats, there was no significant T4 to T3 conversion in cerebellar homogenates, and low rates of T3 to 3,3'-T2 conversion in cerebral cortical homogenates when 100 mM GSH was used instead of DTT. 100 mM GSH was slightly less effective than 1 mM DTT in stimulating T3 to 3,3'-T2 conversion. Subcellular distribution of deiodinating activities. In normal, hypothyroid, and hyperthyroid rats, the extent of conversion of T4 to T3, T4 to rT3, and T3 to 3,3'-T2 was the same, or only slightly less, in the resuspended low-and high-speed pellets as in the whole homogenates. In the hypothyroid rats, the T4 5'-deiodination rate per milligram protein was less in cytosol than in other fractions. In all three groups, the rate of T4 5-deiodination per milligram protein was less in the highspeed supemate than in the high-speed pellet; this was probably true for 5-deiodination of T3 also, after accounting for the decrease in reaction rate as the substrate became largely depleted. Since the amount of the various products were similar in the washed highspeed pellet and in the whole homogenate in all three groups, differences in cytosol binding of T4 clearly did not prevent the detection of T3 production in the whole homogenates of cerebral cortex from normal and hyperthyroid rats.
The effects of dilution of the high-speed pellet was studied.2 In the high-speed pellet from hypothyroid rats, the rate of conversion of T4 to T3 had a reasonably linear, direct relationship to the amount of protein in the incubation tubes between 1.5 and 11. ml. When the high-speed pellet from normal rats was diluted from 8.8 to 1.1 mg/ml, the percent conversion of T4 to rT3 decreased progressively, but the relationship was not linear above 4.4 mg protein/ml.
Inhibition of phenolic and tyrosyl ring deiodination in cerebral cortical tissue by iodothyronines and iopanoic acid. Results are shown in Tables II and  III . Both rT3 and iopanoic acid (Table II) caused dosedependent inhibition ofT4 to T3 conversion. Increasing the T4 concentration from 1 to 1,000 nM also caused a progressive reduction in fractional T4 to T3 conversion (Table II) . The extent of inhibition of fractional T4 to T3 conversion by the agents used in these two experiments may be compared, since total T4 degradation in the incubations with T4 up to 1 nM were quite similar (47.6+3.2% in experiment 1 and 45.0+2.0% in experiment 2). The effect of adding 1,000 nM T3 to the high-speed pellet from hypothyroid rats was the same as in the whole homogenate experiments, i.e., no inhibition of total T3 production. Thus, for the T4 to T3 conversion reaction in the high-speed pellet fraction, the order of inhibitory potency was T4 > iopanoic acid > rT3 > T3.
T3 at 1,000 nM greatly reduced fractional conver- (Table  III) . The potency of iopanoic acid in the inhibition of 5-deiodination of T4 and T3 was approximately equal to that of T4 in the high-speed pellet from normal rats (Table III) . rT3 at 100-and 1,000-nM concentrations did not inhibit T4 to rT3 conversion or T3 to 3,3' -T2 conversion (Table III) . From these data the order of inhibitory potency of these compounds for the 5-deiodination reaction in the cerebral cortical highspeed pellet was T3 = T4 iopanoic acid > rT3.
DISCUSSION
The studies we report here demonstrate complex patterns of deiodinative iodothyronine metabolism in rat brain homogenates. It seems clear that rat brain possesses separate phenolic and tyrosyl ring deiodinases. For both of these enzymes, activity is heat labile and thiol dependent. (30, 31) as being enzymatic reactions. This seems most unlikely for several reasons. First, the processes that form identifiable iodothyronine products of T4 and T3 degradation always behaved as expected for enzymatic reactions. They showed dependence on pH, temperature, and protein concentration, regional specificity within the brain, and dependence on the thyroid status of the animals. Second, we did not observe rapid deiodination of T3 and rT3, the known degradation products of T4, in preboiled homogenates. This result excluded sequential deiodination through those intermediates. Third, all ofthe manipulations that increased excess 1-formation greatly reduced the net formation of all identifiable iodothyronine products. Although the nature ofexcess I-formation is unknown, it appeared to be largely unrelated to formation of iodothyronine products of T4 degradation and may well be nonenzymatic.
The significance of T4 5'-deiodinase activity in the brain, with respect to the responses of the brain to circulating thyroid hormones, is not yet known. Crantz and Larsen (17) have shown that T3 is produced from T4 within the cerebral cortex and the cerebellum of lodothyronine Deiodination in Rat Brain 559 normal rats in vivo. They have recently reported (32) that >70% of the endogenous nuclear T3 in these brain regions is produced locally. This means that local T3 production, compared with T3 transport from the blood, is at least as important in determining occupancy of nuclear T3 binding sites in the cerebral cortex and cerebellum as in the anterior pituitary gland (33, 34) . Local T4 to T3 conversion provides a much lower fraction of nuclear T3 in other tissues (33) (34) (35) . Inhibition by iopanoic acid of T4 5'-deiodination within the anterior pituitary gland prevents physiological doses of T4 from suppressing TSH release in hypothyroid rats in vivo (35) . lopanoic acid inhibits local T4 to T3 conversion in vivo in the rat cerebral cortex and cerebellum (17) , just as it does in pituitary (20) and brain homogenates. Hypothyroidism increases local T4 to T3 conversion in anterior pituitary fragments (22) and probably in the anterior pituitary in vivo (36, 37) . Parallel increases in in vivo T4 5'-deiodinase activity are readily measured in anterior pituitary and brain homogenates in hypothyroidism. These similarities lead us to anticipate that brain T4 5'-deiodinase, the properties of which we are beginning to define in vitro, will prove to be necessary for the expression of some of the effects of blood T4 on the brain. The estimated maximal T3 production rates in cerebral cortical homogenates from hypothyroid rats, 8.1-17.5 fmol T3/min per mg protein, are higher than the T4 to T3 conversion rates we previously measured in cerebral cortical homogenates from normal rats, -1 fmol T3/min per mg protein. In both normal and hypothyroid rats, maximum T4 to T3 conversion rates in anterior pituitary homogenates are times greater than in cerebral cortical homogenates (20) . We have speculated that the increased anterior pituitary T4 5'-deiodinase activity in hypothyroidism could be caused by increased numbers of thyrotrophs (20) . This explanation is obviously inapplicable to brain tissue. It seems more likely, therefore, that metabolic factors are in operation in the brain and the pituitary, e.g., an increased synthesis rate or a decreased turnover rate of the enzyme molecule.
T4 5'-deiodinase activity is also present in rat liver and kidney (19, 21, (38) (39) (40) (41) (42) . The 5'-deiodinase enzymes in liver and kidney are very similar to one another and may well be the same (19, 42) . Rat liver and kidney T4 5'-deiodinases share several properties with rat brain and pituitary T4 5'-deiodinases: inhibition by iopanoic acid and rT3, and lack of apparent interaction with T3 (19, 20, 42, 43) . In these tissues, T4 5'-deiodinase is particulate, and cytosol has very little activity (24, (38) (39) (40) (41) (42) (43) (44) . In at least one important respect, brain and pituitary T4 5'-deiodinase differ from the liver and kidney enzymes: in hypothyroidism, reaction rates in brain and pituitary homogenates are supernormal (20, 22) , while reaction rates in liver and kidney homogenates are subnormal (23, (45) (46) (47) (48) . Further purification will be required to establish the identity or difference between the T4 5'-deiodinase enzymes from these different organs.
Enzymatic tyrosyl ring deiodination of T4 and T3 has been identified in vitro in rat liver and kidney homogenates and in monkey hepatocarcinoma cells (49) (50) (51) (52) (53) (54) (55) . Hepatic T4 to rT3 conversion is thiol dependent and heat labile (50, 52) , and activity is found in particulate fractions as well as in cytosol (50, 54) . These characteristics are similar to those that we find for brain iodothyronine 5-deiodinase. The finding of such substantial iodothyronine 5-deiodinase activity in brain tissue was unexpected, and its significance, if any, is unknown. Our data suggest that rT3 and the other T4 metabolite (very likely 3,3'-T2) found by Dratman and Crutchfield (14) in rat brain tissue after 125I-T4 injection may well be produced within brain tissue in vivo. It is possible that the iodothyronine 5-deiodinase participates in regulation of thyroid hormone effects by providing a mechanism for intracellular T3 disposal, inasmuch as T4 and T3 tyrosyl ring deiodination products produced endogenously have not yet been shown to exert hormonal effects.
From our studies, methodological recommendations for future in vitro studies of production of T4, rT3, and other iodothyronines in brain tissue can be made. Thiol concentration needs to be carefully controlled. Degradation of reaction products needs to be evaluated along with production, because, at least for T3, net increases in T3 can seriously underestimate total T3 production. It is desirable to adjust reaction conditions to minimize excess I production or, at any rate, to take account of the process because it affects substrate concentrations during incubations. Certainly, production of I-from T4 can not be equated with T3 production.
It is becoming increasingly clear that quantitatively and qualitatively distinct patterns of thyroid metabolism occur within various tissues. Even within the brain, the cerebral cortex and the cerebellum exhibit this diversity according to our studies. Clearer understanding of thyroid hormone action will follow from study of intracellular thyroid hormone metabolism. Accumulating evidence suggests that the circulating pool of T4 is a reservoir which is drawn upon to provide substrate for closely regulated, local T3 production. This mechanism may allow tissues to provide themselves with T3 according to their particular requirements for thyroid hormone effects.
